Shenyang Dongxin Pharmaceutical Co., Ltd.
Shenyang Dongxin Pharmaceutical Co., Ltd., commonly referred to as Dongxin Pharma, is a prominent player in the pharmaceutical industry, headquartered in Shenyang, China. Established in 1995, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of antibiotics and cardiovascular medications. With a strong operational presence across various regions in China, Dongxin Pharma is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic drugs and active pharmaceutical ingredients (APIs), distinguished by their efficacy and safety. Dongxin Pharma has achieved notable recognition in the market, positioning itself as a trusted name in the pharmaceutical sector, dedicated to improving healthcare outcomes.
DitchCarbon Score
How does Shenyang Dongxin Pharmaceutical Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shenyang Dongxin Pharmaceutical Co., Ltd.'s score of 15 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Shenyang Dongxin Pharmaceutical Co., Ltd.'s reported carbon emissions
Shenyang Dongxin Pharmaceutical Co., Ltd., headquartered in CN, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company at this time. This absence of data suggests that Shenyang Dongxin Pharmaceutical may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the pharmaceutical industry, companies are increasingly expected to establish clear climate commitments and reduction initiatives to address their environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shenyang Dongxin Pharmaceutical Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
